ANTONAZZO, IPPAZIO COSIMO
 Distribuzione geografica
Continente #
AS - Asia 5.731
NA - Nord America 4.307
EU - Europa 3.398
SA - Sud America 746
AF - Africa 140
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.332
Nazione #
US - Stati Uniti d'America 4.074
SG - Singapore 1.884
IT - Italia 1.349
VN - Vietnam 1.183
CN - Cina 913
HK - Hong Kong 805
RU - Federazione Russa 602
BR - Brasile 547
DE - Germania 390
IE - Irlanda 205
FR - Francia 193
IN - India 151
CA - Canada 149
BD - Bangladesh 146
KR - Corea 146
GB - Regno Unito 135
SE - Svezia 121
ID - Indonesia 114
FI - Finlandia 79
AR - Argentina 77
NL - Olanda 75
IQ - Iraq 61
ZA - Sudafrica 51
MX - Messico 45
ES - Italia 43
TR - Turchia 41
PH - Filippine 37
PL - Polonia 35
SA - Arabia Saudita 35
AT - Austria 34
JP - Giappone 34
CO - Colombia 30
PK - Pakistan 30
UA - Ucraina 29
EC - Ecuador 28
MY - Malesia 23
CH - Svizzera 22
VE - Venezuela 22
EG - Egitto 18
MA - Marocco 17
UZ - Uzbekistan 17
AL - Albania 14
CL - Cile 14
CZ - Repubblica Ceca 14
AE - Emirati Arabi Uniti 13
IR - Iran 13
TN - Tunisia 13
KE - Kenya 11
ET - Etiopia 10
JM - Giamaica 10
IL - Israele 9
NP - Nepal 9
PY - Paraguay 9
AU - Australia 8
JO - Giordania 8
TW - Taiwan 8
UY - Uruguay 8
DZ - Algeria 6
KZ - Kazakistan 6
PT - Portogallo 6
QA - Qatar 6
BE - Belgio 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
LT - Lituania 5
OM - Oman 5
PA - Panama 5
PE - Perù 5
BO - Bolivia 4
GT - Guatemala 4
HN - Honduras 4
HR - Croazia 4
LB - Libano 4
MD - Moldavia 4
MN - Mongolia 4
PS - Palestinian Territory 4
RO - Romania 4
TH - Thailandia 4
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
RS - Serbia 3
AM - Armenia 2
AZ - Azerbaigian 2
BW - Botswana 2
CG - Congo 2
GR - Grecia 2
GY - Guiana 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MK - Macedonia 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NO - Norvegia 2
Totale 14.312
Città #
Singapore 1.118
Hong Kong 789
San Jose 490
Ashburn 488
Milan 367
Ho Chi Minh City 363
Ann Arbor 345
Hanoi 322
Hefei 277
Frankfurt am Main 213
Dublin 195
Dallas 180
New York 174
Los Angeles 140
Seoul 140
The Dalles 135
Chicago 130
Santa Clara 127
Chandler 125
Beijing 103
Rome 101
Toronto 96
Lauterbourg 78
Jakarta 75
São Paulo 71
Munich 63
Boardman 61
Buffalo 61
Moscow 60
London 50
Helsinki 49
Council Bluffs 45
Nuremberg 43
Fairfield 42
Princeton 42
Seattle 42
Bologna 41
Da Nang 38
Haiphong 33
Wilmington 32
Ha Long 31
Tokyo 30
Baghdad 28
Turin 28
Rio de Janeiro 27
Perugia 26
Thái Nguyên 26
Verona 26
Warsaw 26
Altamura 25
Biên Hòa 25
Houston 24
Can Tho 23
Ninh Bình 23
Orem 23
Shanghai 23
Washington 23
Parma 22
Florence 21
Chennai 20
Naples 20
Johannesburg 19
Brooklyn 18
Lappeenranta 18
Lawrence 18
Salt Lake City 18
Mexico City 17
Palermo 17
Woodbridge 17
Jeddah 16
Quận Bình Thạnh 16
Zurich 16
Denver 15
Montreal 15
Phoenix 15
San Diego 15
Tashkent 15
Atlanta 14
Dhaka 14
Hải Dương 14
Osasco 14
Roubaix 14
Vienna 14
Cambridge 13
Guangzhou 13
Hangzhou 13
Madrid 13
Mumbai 13
Kent 12
Stockholm 12
Amsterdam 11
Bắc Giang 11
Bắc Ninh 11
New Delhi 11
Phủ Lý 11
Redondo Beach 11
Tirana 11
Turku 11
Curitiba 10
Elk Grove Village 10
Totale 8.410
Nome #
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 579
Epidemiology of SLE in Italy: an observational study using a primary care database 553
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women 476
Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis 372
Incidence and risk factors for falls among nursing home residents in Italy: a retrospective cohort study 343
Knowledge, Attitudes and Practices Survey of Recombinant Zoster Vaccine among Cardiologists and Cardiac Nurses in Italy 324
Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019 281
Time-Trends in Air Pollution Impact on Health in Italy, 1990–2019: An Analysis From the Global Burden of Disease Study 2019 278
Azithromycin use and outcomes in patients with COVID-19: an observational real-world study 276
Farmacoutilizzazione della terapia per la gestione del paziente con tremore essenziale: uno studio di coorte retrospettivo condotto utilizzando i database dei medici di medicina generale di Regno unito e Francia 265
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases 254
PCSK9 Inhibitors’ New Users: Analysis of Prescription Patterns and Patients’ Characteristics from an Italian Real-world Study 251
Treatment patterns in essential tremor: Real-world evidence from a United Kingdom and France primary care database 250
Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database 238
Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting 237
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 237
Azithromycin use and covid-19: a real-world observational study. 235
COVID-19 e suicidio: uno studio retrospettivo sul territorio di Bergamo e provincia 228
Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis 225
A Cross-Indication Budget Impact Model of Secukinumab for the Treatment of Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis in Italy 225
Il carico di malattia associato ai virus dell'epatite B e C in Europa. Dati dal Global Burden of Disease Study 2019 220
Cost and Cost Effectiveness of Treatments for Psoriatic Arthritis: An Updated Systematic Literature Review 216
Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression 213
Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973) 210
Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study 208
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up 203
The Value of Tucatinib in Metastatic HER2-Positive Breast Cancer Patients: An Italian Cost-Effectiveness Analysis 201
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019: Update From the GBD 2019 Study 201
Hepatitis B and C in Europe: an update from the Global Burden of Disease Study 2019 200
Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy 200
Association between azithromycin use and clinical outcomes in COVID-19 patients: an Italian observational study 198
The psychosocial impact of haemophilia from patients’ and caregivers’ point of view: The results of an Italian survey 197
Patterns and trends of idarucizumab use in an Italian region: A probabilistic record-linkage approach in a real-life setting 188
Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients 185
Analisi della variazione del burden dell’inquinamento atmosferico in Italia dal 1990 al 2019: evidenze dai dati del Global Burden of Disease Study 184
A cost-consequence analysis of adding pertuzumab to the neoadjuvant combination therapy in HER2-positive high-risk early breast cancer in Italy 183
Valutazione dell’impatto della pandemia sugli accessi al sistema sanitario nei territori di Bergamo e Brescia 181
Valutazione della prognosi nei soggetti ospedalizzati con COVID-19 in relazione all’utilizzo pregresso di statine: uno studio osservazionale condotto nelle ATS di Bergamo e Brescia 179
Risk management and drug utilization research 172
Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 165
Impact of covid-19 lockdown, during the two waves, on drug use and emergency department access in people with epilepsy: An interrupted time-series analysis 162
The burden of injury in Central, Eastern, and Western European sub-region: a systematic analysis from the Global Burden of Disease 2019 Study 161
Respiratory Syncytial Virus (RSV) and Intention to Recommend RSV Vaccination: A Cross-Sectional Survey of Cardiologists and Cardiac Nurses in Southern Italy 155
A Multidatabase study of trajectories of antidepressant use in Italy 155
Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019 153
Time trends in the incidence of essential tremor: Evidences from UK and France primary care data 145
Does smoking have an impact on the immunological response to COVID-19 vaccines? Evidence from the VASCO study and need for further studies 145
Impatto dell’epidemia SARS-COV2 sulla gestione dei pazienti affetti da epilessia: un’analisi delle serie storiche interrotte sull’uso degli antiepilettici e l’accesso in pronto soccorso durante le due ondate COVID-19 141
Measuring routine childhood vaccination coverage in 204 countries and territories, 1980–2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1 141
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 126
Raphanus sativus cv. Sango sprout juice decreases diet-induced obesity in sprague dawley rats and ameliorates related disorders 123
Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system 123
Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up—Reply 121
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months 117
Prevalence and determinants of long-term utilization of antidepressant drugs: A retrospective cohort study 116
Human papillomavirus vaccine and demyelinating diseases—A systematic review and meta-analysis 113
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 111
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 110
Diabetes is associated with decreased migraine risk: A nationwide cohort study 107
Drug-induced Kounis syndrome: A matter of pharmacovigilance 107
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 106
The Burden of Chronic Heart Failure in Primary Care in Italy 104
Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy 103
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 102
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 102
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 102
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 101
Digestibility, toxicity and metabolic effects of rapeseed and sunflower protein hydrolysates in mice 100
Real-world evidence and pharmacovigilance: workshop of the Italian Epidemiological Association and of the Italian Society of Pharmacology 97
Signal of potentially protective drug–drug interactions from spontaneous reporting systems: proceed with caution 96
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 96
Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study 95
Editorial: Overcoming boundaries in public health: Advances in international and global health 94
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 90
Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system 89
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System 89
Hepatitis B vaccination and the putative risk of central demyelinating diseases – A systematic review and meta-analysis 85
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 84
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements 82
Timing of hepatitis B and C virus elimination in Europe: a picture from the Global Burden of Disease Study 2019 79
Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres 74
Totale 14.633
Categoria #
all - tutte 53.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 0 0 0 0 0 0 45
2021/2022451 51 44 42 39 49 20 46 23 21 32 37 47
2022/2023834 44 211 69 45 71 72 158 39 41 25 24 35
2023/20241.358 42 80 71 123 162 262 139 64 127 44 105 139
2024/20253.445 173 332 133 189 287 180 249 120 368 490 328 596
2025/20268.206 1.310 790 581 878 816 398 1.108 324 569 637 304 491
Totale 14.633